Cita APA

Del Giudice, F., Flammia, R., Chung, B., Moschini, M., Pradere, B., Mari, A., . . . Busetto, G. (2022). Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis.

Citación estilo Chicago

Del Giudice, F., et al. Compared Efficacy of Adjuvant Intravesical BCG-TICE Vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis. 2022.

Cita MLA

Del Giudice, F., et al. Compared Efficacy of Adjuvant Intravesical BCG-TICE Vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis. 2022.